Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (311-320 of 692) with videos related to

Pageof 70
Sort By:
BMC Cancer|July 5, 2011
The use of erlotinib in daily practice: a study on adherence and patients' experiencesLonneke Timmers, Christel C L M Boons, Dirk Mangnus, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?Daphne van der Geest, Alex van Vliet, Daniel S Peeper, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A phase II EORTC study of temozolomide in patients with malignant pleural mesotheliomaJ P van Meerbeeck, P Baas, C Debruyne, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2012
An 82-year-old woman with small-cell lung cancer: relapse after 9 years or a new primary?Martijn R Groenendijk, Erik Thunnissen, Bauke Ylstra, et al.
EJNMMI Research|June 10, 2015
Pilot study of (89)Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancerIdris Bahce, Marc C Huisman, Eline E Verwer, et al.
British Journal of Cancer|October 20, 2012
VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenibJ L Kuiper, J S W Lind, H J M Groen, et al.
British Journal of Cancer|August 16, 2006
Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)E C J Phernambucq, B Biesma, E F Smit, et al.
Proteomics. Clinical Applications|April 5, 2016
Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancerMaria Rovithi, Joline S W Lind, Thang V Pham, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancerC Dickhoff, M Dahele, M A Paul, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 16, 2012
Trimodality therapy for superior sulcus tumours: evolution and evaluation of a treatment protocolC G Vos, K J Hartemink, J L G Blaauwgeers, et al.
Pageof 70

Showing results (311-320 of 692) with videos related to

Sort By:
Pageof 70
BMC Cancer|July 5, 2011
The use of erlotinib in daily practice: a study on adherence and patients' experiencesLonneke Timmers, Christel C L M Boons, Dirk Mangnus, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?Daphne van der Geest, Alex van Vliet, Daniel S Peeper, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A phase II EORTC study of temozolomide in patients with malignant pleural mesotheliomaJ P van Meerbeeck, P Baas, C Debruyne, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2012
An 82-year-old woman with small-cell lung cancer: relapse after 9 years or a new primary?Martijn R Groenendijk, Erik Thunnissen, Bauke Ylstra, et al.
EJNMMI Research|June 10, 2015
Pilot study of (89)Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancerIdris Bahce, Marc C Huisman, Eline E Verwer, et al.
British Journal of Cancer|October 20, 2012
VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenibJ L Kuiper, J S W Lind, H J M Groen, et al.
British Journal of Cancer|August 16, 2006
Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)E C J Phernambucq, B Biesma, E F Smit, et al.
Proteomics. Clinical Applications|April 5, 2016
Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancerMaria Rovithi, Joline S W Lind, Thang V Pham, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancerC Dickhoff, M Dahele, M A Paul, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 16, 2012
Trimodality therapy for superior sulcus tumours: evolution and evaluation of a treatment protocolC G Vos, K J Hartemink, J L G Blaauwgeers, et al.
Pageof 70